Paul is a clinical pharmacologist, pharmaceutical physician and pain physician. He trained in medicine and subseqeuently in clinical pharmacology at the University of Adelaide. After obtaining specialist qualifications Paul spent nearly 20 years in the UK in the development of new medicines. He has been Principal Investigator in over 650 clinical research studies and has been an active Consultant, both to the pharmaceutical industry as well as an invited speaker to the FDA.
Paul returned to the University of Adelaide in 2005. His major clinical and academic interest is in chronic pain and headache, focusing on the development of biomarkers, evaluation of novel therapies and mechanisms of disease. Paul returned to the University in October 2016 as Director of Innovation.